CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Structural Modifications of the Triazolo-thiadiazole Derivatives as DOT1L Inhibitors and Their Activities
Xu Xiaoming2; Guo Siqi1,3; Zhang Jing2; Chen Yantao1; Kang Yaqing2; Liu Na2; Liu Junfang2; Luo Cheng1; Chen Shijie1; Chen Hua2
刊名CHINESE JOURNAL OF ORGANIC CHEMISTRY
2020-05-25
卷号40期号:5页码:1345-1354
关键词DOT1L inhibitor ttriazolo-thiadiazole structural modification hydrophobic substituent structure-activity analysis
ISSN号0253-2786
DOI10.6023/cjoc201911012
通讯作者Chen Shijie(shijiechen@simm.ac.cn) ; Chen Hua(hua-todd@163.com)
英文摘要A series of novel derivatives containing triazolo-thiadiazole moiety have been synthesized by structural modifications on a lead disruptor of telomeric silencing 1-like (DOT1L) inhibitor 8. All the compounds have been evaluated for their DOT1L inhibitory activities at the concentration of 50 mu mol/L. The results showed that the tested compounds showed certain DOT1L inhibitory activities. Among them, N,N-dimethyl-4-(6-methyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl)aniline (14b) and (R)-tert-butyl (1-((3-(4-(dimethylamino)phenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl)methyl)-piperidin-3-yl)carbamate (16a) were the best ones with IC50 values of 7.37 and 7.84 mu mol/L, respectively, near that of the positive control 8. The structure-activity analysis showed that when the triazolo-thiadiazole moiety occupied the binding-site of S-adenosylmethionine (SAM) in DOT1L and R-1 group was 4-N,N-dimethyl, the hydrophobic substituents as the tailed R-2 groups would be accommodated into the DOT1L binding site, and the sizes of the substituents seemed no effects on their DOT1L inhibitory activities of the compounds.
资助项目Natural Science Interdisciplinary Research Program of Hebei University[DXK201903]
WOS关键词ACCURATE DOCKING ; LEUKEMIA-CELLS ; POTENT ; DESIGN ; GLIDE ; DISRUPTOR ; DISCOVERY
WOS研究方向Chemistry
语种英语
出版者SCIENCE PRESS
WOS记录号WOS:000550196500026
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/292000]  
专题中国科学院上海药物研究所
通讯作者Chen Shijie; Chen Hua
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
2.Hebei Univ, Coll Chem & Environm Sci, Key Lab Chem Biol Hebei Prov, Baoding 071002, Hebei, Peoples R China
3.Nanchang Univ, Sch Pharm, Nanchang 330006, Jiangxi, Peoples R China
推荐引用方式
GB/T 7714
Xu Xiaoming,Guo Siqi,Zhang Jing,et al. Structural Modifications of the Triazolo-thiadiazole Derivatives as DOT1L Inhibitors and Their Activities[J]. CHINESE JOURNAL OF ORGANIC CHEMISTRY,2020,40(5):1345-1354.
APA Xu Xiaoming.,Guo Siqi.,Zhang Jing.,Chen Yantao.,Kang Yaqing.,...&Chen Hua.(2020).Structural Modifications of the Triazolo-thiadiazole Derivatives as DOT1L Inhibitors and Their Activities.CHINESE JOURNAL OF ORGANIC CHEMISTRY,40(5),1345-1354.
MLA Xu Xiaoming,et al."Structural Modifications of the Triazolo-thiadiazole Derivatives as DOT1L Inhibitors and Their Activities".CHINESE JOURNAL OF ORGANIC CHEMISTRY 40.5(2020):1345-1354.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace